Almobarak, Bilal
Amlani, Vishal
Inge, Linda
Hofving, Tobias
Muth, Andreas
Nilsson, Ola
Johansson, Martin
Arvidsson, Yvonne
Elias, Erik
Funding for this research was provided by:
Assar Gabrielsson Research Foundation
Sahlgrenska University Hospital Funds
Swedish Cancer Society
Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement
BioCARE National Strategic Research Program
University of Gothenburg
Article History
Received: 21 March 2022
Accepted: 9 March 2023
First Online: 23 March 2023
Declarations
:
: We obtained approval from Regional Ethical Review Boards in Gothenburg, Sweden, for the use of clinical materials for research purposes (Dnr 833 − 18) and publishing of the results. All experiments were performed in accordance the Declaration of Helsinki. Consent was obtained from each patient in accordance with requirements from the current and previous ethics permits. Patients included from 2018 and onwards provided a separate written informed consent and patients included before 2018 provided verbal informed consent that was separately documented in the patients’ medical journal.
: Not applicable.
: The authors have no conflicts of interest to declare.